title: Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards?
abstract: BACKGROUND
  Standards for the detection of adenomas during screening colonoscopy are widely used to measure examination quality. No such standards exist for sessile serrated adenomas (SSAs).
  
  
  OBJECTIVE
  To measure both the adenoma detection rate (ADR) and SSA detection rate (SSADR) during screening colonoscopy before and after quality improvement/financial incentive measures.
  
  
  METHODS
  Retrospective determination of baseline ADR/SSADR by the endoscopist, followed by prospective collection of data after informing physicians of baseline detection rates.
  
  
  METHODS
  Tertiary cancer center with a large cancer screening program.
  
  
  METHODS
  A total of 2833 average-risk colorectal cancer screening patients 50 to 75 years of age undergoing initial colonoscopy.
  
  
  METHODS
  Electronic medical records for indication and demographics, endoscopy report, and pathology report.
  
  
  METHODS
  Detection rates of adenomas and SSAs by sex.
  
  
  RESULTS
  The overall ADR in male and female patients was 50.6% and 36.6%, respectively. The overall detection rate of advanced adenomas in male and female patients was 12.4% and 6.5%, respectively. The overall SSADR in male and female patients was 10.1% and 7.1%, respectively. In 108 patients (3.8% of entire group), SSAs were the only premalignant lesions found. Detection rates of both types of premalignant polyps improved over time but did not reach statistical significance.
  
  
  CONCLUSIONS
  Single-center experience with limited sample size and small group of endoscopists.
  
  
  CONCLUSIONS
  ADRs far in excess of current standards are achievable. Cecal withdrawal time is associated with the ADR. Prevalence of SSA rivals that of advanced adenomas and is greater than current medical literature suggests. The combination of monitoring and financial incentives did not result in statistically significant improvement in ADRs.
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: William A
authors.initials: WA
authors.lastname: Ross
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Selvi
authors.initials: S
authors.lastname: Thirumurthi
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Lynch
authors.affiliation: Department of Pathology, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Asif
authors.initials: A
authors.lastname: Rashid
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Mala
authors.initials: M
authors.lastname: Pande
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Mehnaz A
authors.initials: MA
authors.lastname: Shafi
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Lee
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Gottumukkala S
authors.initials: GS
authors.lastname: Raju
mesh_terms: D000236:Adenoma / Q000175:diagnosis*; D000368:Aged; D003111:Colonic Polyps / Q000175:diagnosis*; D003113:Colonoscopy / Q000592:standards*; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D055088:Early Detection of Cancer / Q000592:standards*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D058996:Quality Improvement; D012189:Retrospective Studies